aTyr Pharma Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Net Income	-50.39	-45.34	-33.77	-16.22	-23.6	-34.52	-48.21	-57.86	-47.99	-24.77	Upgrade
Depreciation & Amortization	2.74	1.7	1.3	1.27	1.37	0.75	0.71	0.9	0.87	0.83	Upgrade
Share-Based Compensation	2.6	2.15	1.61	1.47	1.78	3.43	6.78	5.03	4.86	1.79	Upgrade
Other Operating Activities	11.83	-0.4	-2.23	-1.81	0.44	-0.73	-1.65	-0.94	5.45	-1.09	Upgrade
Operating Cash Flow	-33.22	-41.89	-33.08	-15.3	-20.01	-31.06	-42.36	-52.86	-36.8	-22.82	Upgrade
Capital Expenditures	-4.2	-1.46	-0.14	-0.18	-0.03	-0.59	-1.31	-0.6	-0.66	-0.25	Upgrade
Change in Investments	-15.93	48.71	-91.42	7.08	4.95	37.77	-26.33	34.13	-71.33	-2	Upgrade
Investing Cash Flow	-20.13	47.25	-91.57	6.9	4.93	37.17	-27.64	33.53	-71.99	-2.25	Upgrade
Share Issuance / Repurchase	66.62	5.52	110.03	25.23	9.34	0.43	42.84	0.16	77.51	-0.93	Upgrade
Debt Issued / Paid	-0.39	-0.07	0	-9.08	-8	-4.67	9.87	4.53	-5.24	3.44	Upgrade
Other Financing Activities	-	-	-	-	-	-	-	-	75.65	-	Upgrade
Financing Cash Flow	66.23	5.45	110.03	16.14	1.34	-4.24	52.7	4.7	147.92	2.51	Upgrade
Net Cash Flow	12.88	10.81	-14.62	7.74	-13.75	1.87	-17.3	-14.64	39.13	-22.56	Upgrade
Free Cash Flow	-37.42	-43.35	-33.22	-15.49	-20.04	-31.66	-43.68	-53.46	-37.46	-23.07	Upgrade
Free Cash Flow Margin	-10600.85%	-417.37%	-	-148.11%	-4749.05%	-	-	-	-	-	Upgrade
Free Cash Flow Per Share	-0.70	-1.52	-1.74	-1.69	-5.97	-14.78	-23.67	-31.57	-33.11	-387.21	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).